Skip to main content
Erschienen in: Journal of Neurology 12/2020

25.07.2020 | Original Communication

Direct thrombectomy for stroke in the presence of absolute exclusion criteria for thrombolysis

verfasst von: Manuel Cappellari, Giovanni Pracucci, Stefano Forlivesi, Valentina Saia, Nicola Limbucci, Patrizia Nencini, Domenico Inzitari, Valerio Da Ros, Fabrizio Sallustio, Stefano Vallone, Guido Bigliardi, Andrea Zini, Sergio Lucio Vinci, Cristina Dell’Aera, Sandra Bracco, Samuele Cioni, Rossana Tassi, Mauro Bergui, Andrea Naldi, Giuseppe Carità, Cristiano Azzini, Ilaria Casetta, Roberto Gasparotti, Mauro Magoni, Lucio Castellan, Cinzia Finocchi, Roberto Menozzi, Umberto Scoditti, Francesco Causin, Federica Viaro, Edoardo Puglielli, Alfonsina Casalena, Maria Ruggiero, Sara Biguzzi, Davide Castellano, Roberto Cavallo, Guido Andrea Lazzarotti, Giovanni Orlandi, Alessandro Sgreccia, Maria Federica Denaro, Nicola Cavasin, Adriana Critelli, Elisa Francesca Maria Ciceri, Bruno Bonetti, Luigi Chiumarulo, Marco Petruzzelli, Carlo Pellegrino, Federico Carimati, Nicola Burdi, Maria Pia Prontera, Wiliam Auteri, Alfredo Petrone, Giulio Guidetti, Ettore Nicolini, Giuseppe Ganci, Annalisa Sugo, Pietro Filauri, Simona Sacco, Guido Squassina, Paolo Invernizzi, Nunzio Paolo Nuzzi, Manuel Corato, Pietro Amistà, Mauro Gentile, Stefano Barbero, Federica Schirru, Giuseppe Craparo, Marina Mannino, Luigi Simonetti, Salvatore Mangiafico, Danilo Toni

Erschienen in: Journal of Neurology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Intravenous thrombolysis (IVT)-ineligible patients undergoing direct thrombectomy tended to have poorer functional outcome as compared with IVT-eligible patients undergoing bridging therapy. We aimed to assess radiological and functional outcomes in large vessel occlusion-related stroke patients receiving direct thrombectomy in the presence of absolute exclusion criteria for IVT vs relative exclusion criteria for IVT and vs non-exclusion criteria for IVT.

Methods

A cohort study on prospectively collected data from 2282 patients enrolled in the Italian Registry of Endovascular Treatment in Acute Stroke cohort for treatment with direct thrombectomy (n = 486, absolute exclusion criteria for IVT alone; n = 384, absolute in combination with relative exclusion criteria for IVT; n = 777, relative exclusion criteria for IVT alone; n = 635, non-exclusion criteria for IVT).

Results

After adjustment for unbalanced variables (model 1), ORs for 3-month death was higher in the presence of absolute exclusion criteria for IVT alone (vs relative exclusion criteria for IVT alone) (1.595, 95% CI 1.042–2.440) and in the presence of absolute exclusion criteria for IVT alone (vs non-exclusion criteria for IVT) (1.235, 95% CI 1.014–1.504). After adjustment for predefined variables (model 2: age, sex, pre-stroke mRS ≤ 1, NIHSS, occlusion in the anterior circulation, onset-to-groin time, and procedure time), ORs for 3-month death was higher in the presence of absolute exclusion criteria for IVT alone (vs relative exclusion criteria for IVT alone) (1.235, 95% CI 1.014–1.504) and in the presence of absolute exclusion criteria for IVT alone (vs non-exclusion criteria for IVT) (1.246, 95% CI 1.039–1.495). No significant difference was found between the groups as regards any type of intracerebral hemorrhage and parenchymal hematoma within 24 h, successful and complete recanalization after procedure, and modified Rankin Scale score 0–2 at 3 months. After adjustment for predefined variables of model 2, ORs for death were higher in the presence of recent administration of IV heparin (OR: 2.077), platelet count < 100,000/mm3 (OR: 4.798), bacterial endocarditis (OR: 15.069), neoplasm with increased hemorrhagic risk (OR: 6.046), and severe liver disease (OR: 6.124).

Conclusions

Radiological outcomes were similar after direct thrombectomy in patients with absolute, relative, and non- exclusion criteria for IVT, while an increase of fatal outcome was observed in the presence of some absolute exclusion criterion for IVT.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Berkhemer OA, Fransen PS, Beumer D et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372:11–20CrossRef Berkhemer OA, Fransen PS, Beumer D et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372:11–20CrossRef
2.
Zurück zum Zitat Goyal M, Demchuk AM, Menon BK et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372:1019–1030CrossRef Goyal M, Demchuk AM, Menon BK et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372:1019–1030CrossRef
3.
Zurück zum Zitat Saver JL, Goyal M, Bonafe A et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372:2285–2295CrossRef Saver JL, Goyal M, Bonafe A et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372:2285–2295CrossRef
4.
Zurück zum Zitat Campbell BC, Mitchell PJ, Kleinig TJ et al (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372:1009–1018CrossRef Campbell BC, Mitchell PJ, Kleinig TJ et al (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372:1009–1018CrossRef
5.
Zurück zum Zitat Jovin TG, Chamorro A, Cobo E et al (2015) Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372:2296–2306CrossRef Jovin TG, Chamorro A, Cobo E et al (2015) Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372:2296–2306CrossRef
6.
Zurück zum Zitat Powers WJ, Rabinstein AA, Ackerson T et al (2018) 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49:e46–e110CrossRef Powers WJ, Rabinstein AA, Ackerson T et al (2018) 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49:e46–e110CrossRef
7.
Zurück zum Zitat Albers GW, Marks MP, Kemp S et al (2018) Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378:708–718CrossRef Albers GW, Marks MP, Kemp S et al (2018) Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378:708–718CrossRef
8.
Zurück zum Zitat Nogueira RG, Jadhav AP, Haussen DC et al (2018) Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 378:11–21CrossRef Nogueira RG, Jadhav AP, Haussen DC et al (2018) Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 378:11–21CrossRef
9.
Zurück zum Zitat Toni D, Mangiafico S, Agostoni E et al (2015) Intravenous thrombolysis and intra-arterial interventions in acute ischemic stroke: Italian Stroke Organisation (ISO)-SPREAD Guidelines. Int J Stroke 10:1119–1129CrossRef Toni D, Mangiafico S, Agostoni E et al (2015) Intravenous thrombolysis and intra-arterial interventions in acute ischemic stroke: Italian Stroke Organisation (ISO)-SPREAD Guidelines. Int J Stroke 10:1119–1129CrossRef
10.
Zurück zum Zitat Mulder MJ, Berkhemer OA, Fransen PS et al (2016) Treatment in patients who are not eligible for intravenous alteplase: MR CLEAN subgroup analysis. Int J Stroke 11:637–645CrossRef Mulder MJ, Berkhemer OA, Fransen PS et al (2016) Treatment in patients who are not eligible for intravenous alteplase: MR CLEAN subgroup analysis. Int J Stroke 11:637–645CrossRef
11.
Zurück zum Zitat Kaesmacher J, Mordasini P, Arnold M et al (2019) Direct mechanical thrombectomy in tPA-ineligible and -eligible patients versus the bridging approach: a meta-analysis. J Neurointerv Surg 11:20–27CrossRef Kaesmacher J, Mordasini P, Arnold M et al (2019) Direct mechanical thrombectomy in tPA-ineligible and -eligible patients versus the bridging approach: a meta-analysis. J Neurointerv Surg 11:20–27CrossRef
12.
Zurück zum Zitat Gensicke H, Al Sultan AS, Strbian D et al (2018) Intravenous thrombolysis and platelet count. Neurology 90:e690–e697CrossRef Gensicke H, Al Sultan AS, Strbian D et al (2018) Intravenous thrombolysis and platelet count. Neurology 90:e690–e697CrossRef
13.
Zurück zum Zitat Asaithambi G, Adil MM, Qureshi A (2013) Thrombolysis for ischemic stroke associated with infective endocarditis: results from the nationwide inpatient sample. Stroke 44:2917–2919CrossRef Asaithambi G, Adil MM, Qureshi A (2013) Thrombolysis for ischemic stroke associated with infective endocarditis: results from the nationwide inpatient sample. Stroke 44:2917–2919CrossRef
14.
Zurück zum Zitat Giugliano RP, McCabe CH, Antman EM et al (2001) Thrombolysis in Myocardial Infarction (TIMI) Investigators. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage. Am Heart J 141:742–750CrossRef Giugliano RP, McCabe CH, Antman EM et al (2001) Thrombolysis in Myocardial Infarction (TIMI) Investigators. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage. Am Heart J 141:742–750CrossRef
15.
Zurück zum Zitat Murthy SB, Karanth S, Shah S et al (2013) Thrombolysis for acute ischemic stroke in patients with cancer: a population study. Stroke 44:3573–3576CrossRef Murthy SB, Karanth S, Shah S et al (2013) Thrombolysis for acute ischemic stroke in patients with cancer: a population study. Stroke 44:3573–3576CrossRef
16.
Zurück zum Zitat Forlivesi S, Cappellari M, Baracchini C et al (2019) Intravenous thrombolysis for ischemic stroke in the Veneto region: the gap between eligibility and reality. J Thromb Thrombolysis 47:113–120CrossRef Forlivesi S, Cappellari M, Baracchini C et al (2019) Intravenous thrombolysis for ischemic stroke in the Veneto region: the gap between eligibility and reality. J Thromb Thrombolysis 47:113–120CrossRef
17.
Zurück zum Zitat Desai SM, Mehta A, Morrison AA et al (2019) Endovascular thrombectomy, platelet count, and intracranial hemorrhage. World Neurosurg 127:e1039–e1043CrossRef Desai SM, Mehta A, Morrison AA et al (2019) Endovascular thrombectomy, platelet count, and intracranial hemorrhage. World Neurosurg 127:e1039–e1043CrossRef
18.
Zurück zum Zitat Mönch S, Boeckh-Behrens T, Kreiser K et al (2019) Thrombocytopenia and declines in platelet counts: predictors of mortality and outcome after mechanical thrombectomy. J Neurol 266:1588–1595CrossRef Mönch S, Boeckh-Behrens T, Kreiser K et al (2019) Thrombocytopenia and declines in platelet counts: predictors of mortality and outcome after mechanical thrombectomy. J Neurol 266:1588–1595CrossRef
19.
Zurück zum Zitat Lee D, Lee DH, Suh DC et al (2019) Intra-arterial thrombectomy for acute ischaemic stroke patients with active cancer. J Neurol 266:2286–2293CrossRef Lee D, Lee DH, Suh DC et al (2019) Intra-arterial thrombectomy for acute ischaemic stroke patients with active cancer. J Neurol 266:2286–2293CrossRef
20.
Zurück zum Zitat Rinaldo L, Cloft HJ, Rangel Castilla L et al (2019) Utilization rates of tissue plasminogen activator and mechanical thrombectomy in patients with acute stroke and underlying malignancy. J Neurointerv Surg 11:768–771CrossRef Rinaldo L, Cloft HJ, Rangel Castilla L et al (2019) Utilization rates of tissue plasminogen activator and mechanical thrombectomy in patients with acute stroke and underlying malignancy. J Neurointerv Surg 11:768–771CrossRef
21.
Zurück zum Zitat Nogueira RG, Smith WS (2009) Safety and efficacy of endovascular thrombectomy in patients with abnormal hemostasis: pooled analysis of the MERCI and multi MERCI trials. Stroke 40:516–522CrossRef Nogueira RG, Smith WS (2009) Safety and efficacy of endovascular thrombectomy in patients with abnormal hemostasis: pooled analysis of the MERCI and multi MERCI trials. Stroke 40:516–522CrossRef
22.
Zurück zum Zitat Pericart L, Bernard A, Bourguignon T et al (2017) Comparison of outcome of possible versus definite infective endocarditis involving native heart valves. Am J Cardiol 119:1854–1861CrossRef Pericart L, Bernard A, Bourguignon T et al (2017) Comparison of outcome of possible versus definite infective endocarditis involving native heart valves. Am J Cardiol 119:1854–1861CrossRef
23.
Zurück zum Zitat Parikh NS, Merkler AE, Schneider Y et al (2017) Discharge disposition after stroke in patients with liver disease. Stroke 48:476–478CrossRef Parikh NS, Merkler AE, Schneider Y et al (2017) Discharge disposition after stroke in patients with liver disease. Stroke 48:476–478CrossRef
Metadaten
Titel
Direct thrombectomy for stroke in the presence of absolute exclusion criteria for thrombolysis
verfasst von
Manuel Cappellari
Giovanni Pracucci
Stefano Forlivesi
Valentina Saia
Nicola Limbucci
Patrizia Nencini
Domenico Inzitari
Valerio Da Ros
Fabrizio Sallustio
Stefano Vallone
Guido Bigliardi
Andrea Zini
Sergio Lucio Vinci
Cristina Dell’Aera
Sandra Bracco
Samuele Cioni
Rossana Tassi
Mauro Bergui
Andrea Naldi
Giuseppe Carità
Cristiano Azzini
Ilaria Casetta
Roberto Gasparotti
Mauro Magoni
Lucio Castellan
Cinzia Finocchi
Roberto Menozzi
Umberto Scoditti
Francesco Causin
Federica Viaro
Edoardo Puglielli
Alfonsina Casalena
Maria Ruggiero
Sara Biguzzi
Davide Castellano
Roberto Cavallo
Guido Andrea Lazzarotti
Giovanni Orlandi
Alessandro Sgreccia
Maria Federica Denaro
Nicola Cavasin
Adriana Critelli
Elisa Francesca Maria Ciceri
Bruno Bonetti
Luigi Chiumarulo
Marco Petruzzelli
Carlo Pellegrino
Federico Carimati
Nicola Burdi
Maria Pia Prontera
Wiliam Auteri
Alfredo Petrone
Giulio Guidetti
Ettore Nicolini
Giuseppe Ganci
Annalisa Sugo
Pietro Filauri
Simona Sacco
Guido Squassina
Paolo Invernizzi
Nunzio Paolo Nuzzi
Manuel Corato
Pietro Amistà
Mauro Gentile
Stefano Barbero
Federica Schirru
Giuseppe Craparo
Marina Mannino
Luigi Simonetti
Salvatore Mangiafico
Danilo Toni
Publikationsdatum
25.07.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 12/2020
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-020-10098-w

Weitere Artikel der Ausgabe 12/2020

Journal of Neurology 12/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.